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New protocol for HIV screening for life 
assurance
To the Editor: The insurance industry has used the third-
generation ELISA protocol as a screening test for human 
immunodeficiency virus (HIV) infection over the last number 
of years. In order to utilise new technology and keep up with 
developments in the clinical field, the fourth-generation Combi 
protocol has been developed in consultation with experts and 
discussion with the National Pathology Group. The third-
generation protocol will be used concurrently with the fourth-
generation protocol for the next 2 years.
This protocol uses one of the LOASPA approved fourth-
generation combination HIV tests (Combi test). The Combi tests 
for both the HIV antibodies and the virus itself (P24, antigen 
component), shortening the window period from an average of 
16 days to an average of 7 days.
The Medical and Underwriting Standing Committee (MUSC) 
of the Life Offices’ Association of South Africa (LOA) has 
extensively investigated the results of the new test on local 
blood samples for the last 18 months. The aim was to ensure 
that there is not an increase in the false-positive test ratio, as 
this has serious implications. Two major studies have been 
done by Ampath and the University of Pretoria to compare the 
existing ELISA tests to the combination tests. The latter study is 
ongoing.
As with all underwriting tests, as well as the previous 
protocol, these tests must be regarded as screening tests and 
further testing is recommended in the event of a reactive test. 
Any further tests will be for the client’s own cost.
A non-reactive Combi test result is reported as such and no 
follow-up test is done. A new category of ‘low-reactive’ results 
has been defined. Any low-reactive or reactive result will be 
retested with a third-generation ELISA immuno-assay to retest 
the antibody component. If this does not confirm the result of 
the first test, it will be followed with a P24 antigen test to retest 
the antigen component. Any low-reactive third-generation test 
will also be followed with a P-2 antigen test. All second and 
third line follow-up tests will be from a different manufacturer 
than that of the Combi test (Fig. 1).  
Cut-off values for ‘reactive’ as well as ‘low reactive’ results 
for all approved third-generation ELISAs, as well as fourth-
generation Combi tests, will be defined from time to time by 
mutual agreement between the National Pathology Group 
and the Medical and Underwriting Standing Committee of the 
LOA.
The LOA is confident that the use of ‘low-reactive’ values 
with sequential follow-up tests of both the antigen and 
antibody components will reduce the possible number of false- 
reactive results to a minimum.
Further information is available on http://www.loa.co.za 
Chapter 6 HIV Testing Protocol.
Maritha van der Walt
On behalf of Medical and Underwriting Standing Committee of the LOA (MUSC)
2 Riebeeck Street
Cape Town
info@loa.co.za
Streptococcus pneumoniae infections in 
neonates
To the Editor: While Streptococcus pneumoniae bacteraemia is not 
uncommon, clinicians and microbiologists might not think of it 
in terms of neonatal sepsis. Our interest was aroused recently 
by two cases of S. pneumoniae bacteraemia in neonates.
A 21-year-old primigravida had a spontaneous rupture of 
membranes at 34 weeks’ gestation with clear liquor and no 
clinical or laboratory features of sepsis. She received intrave-
nous ampicillin and metronidazole, and had a normal vaginal 
delivery approximately 40 hours after the rupture of mem-
branes. At delivery the baby had good Apgar scores of 9 and 
9, but was noted to be in respiratory distress with tachypnoea 
(respiratory rate of 72 breaths/minute), grunting and subcostal 
and intercostal recession. He was commenced on intravenous 
penicillin and gentamicin. S. pneumoniae was cultured from the 
blood, susceptible to penicillin (MIC as determined by Etest 
of 0.016 µg/ml). He had a good clinical response to 10 days of 
intravenous penicillin.
A 19-year-old HIV-infected primigravida on highly active an-
tiretroviral therapy (HAART) developed spontaneous rupture 
of membranes at 28 weeks’ gestation and had a normal vaginal 
delivery approximately 24 hours after rupture of membranes. 
There was no clinical evidence of sepsis or chorioamnionitis. 
The mother received no intrapartum antibiotics. At delivery, the 
baby weighted 985 g and had Apgar scores of 4, 7 and 9 at 1, 5 
and 10 minutes respectively. Subsequently he was noted to have 
alar flaring, subcostal and intercostal recession and grunting. 
He was transferred to the neonatal intensive care unit where he 
received ventilation, intravenous penicillin and gentamicin, and 
surfactant. The baby responded well to 10 days of intravenous 
penicillin. S. pneumoniae was cultured from the blood and the 
isolate was susceptible to penicillin (MIC of 0.012 µg/ml).
First-line test Combi: Reactive
Second-line test
Third-generation ELISA
Reactive Non-reactive or low-reactive
Third-line test No third-line test P-24 AG
Fig. 1. New fourth-generation HIV test protocol.
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S. pneumoniae is an uncommon, but potentially serious neo-
natal pathogen. Earlier literature stressed early-onset disease 
with S. pneumoniae, similar to neonatal group B streptococcal 
infections. Most cases of early-onset disease are associated with 
prematurity and prolonged rupture of membranes. Infection is 
presumed to be acquired from the mother intra partum, either 
transplacentally or via ascending infection, as is likely in both 
the cases reported here, given the rapidity of onset of disease 
and that both mothers were clinically well. While S. pneumoniae 
is not considered to be part of the normal vaginal flora, tran-
sient pelvic colonisation can occur. Pneumococcal pelvic infec-
tions may occur in association with surgery, foreign bodies or 
delivery, and mothers may have invasive pneumoccal disease, 
e.g. meningitis.
Late-onset pneumococcal disease among neonates has been 
reported. In a study of S. pneumoniae infections in the neonate 
(SPIN) the mean age of onset was 18.1 days and 90% of the 
infants were term babies (≥ 38 weeks’ gestation). The source of 
acquisition of pneumococci in late-onset infections is not clear. 
Vertical transmission from the mother and horizontal transmis-
sion from siblings and other adults may occur.
Because of difficulties in diagnosis, the true incidence of S. 
pneumoniae infection in neonates is unknown. In developing 
countries S. pneumoniae probably causes about 25% of neonatal 
pneumonia and this may be becoming more frequent, particu-
larly with HIV co-infection.
Neonatal diagnosis of S. pneumoniae sepsis has had limited 
significance since the infection would be adequately treated by 
empiric regimens for neonatal  sepsis including penicillin. This 
may change with the increasing prevalence of non-susceptibil-
ity of S. pneumoniae to penicillin, particularly where meningitis 
cannot be excluded. In these settings a third-generation cepha-
losporin (such as cefotaxime or ceftriaxone) would be more 
appropriate. If resistance to the third-generation cephalosporins 
is prevalent, vancomycin may be indicated.
C Bamford 
A Whitelaw
S Haffejee
Department of Medical Microbiology
Groote Schuur Hospital/National Health Laboratory Service
Cape Town
cbamford@sun.ac.za
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Educating bonesetters
To the Editor: We appreciate the noble work of Dr Onuminya 
in his community.1 However, the attempt to bridge the gap be-
tween orthodox and traditional medicine is not new.  Shah et al.2 
undertook training programmes for rural health practitioners 
in Nepal. At evaluation after 6 years they found significant im-
provements in the knowledge base and working skills of these 
practitioners after undergoing training programmes. In a 2-year 
prospective study, Eshete3 found a reduction in amputation 
rates after a one-day instructional course offered to bonesetters 
in Ethiopia.
Because of local high patronage it seems that the traditional 
system of bone setting is here to stay. The above pilot reports1-3  
indicate that it is possible to educate bone setters and reduce 
morbidity. Because of widespread prevalence of bonesetters 
in developing countries (in India it is estimated that there are 
70 000 traditional healers and bonesetters who treat 60% of all 
trauma patients), a national initiative is required to include 
them in the mainstream health care systems of developing 
countries. These bonesetters often work in remote places and 
villages where there are no trained doctors. With some basic 
education and training in the field of orthopaedic care they can 
become a most effective vehicle for patient care and referral.
Anil Agarwal
Manoj Kumar Goyal
Department of Orthopaedics
UCMS and GTB Hospital
Shahdara
Delhi 
India
rachna.anila@yahoo.co.in
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Does access to better housing affect  
personal quality of life and well-being?
To the Editor: Since 1994 a concerted effort has been underway 
to improve the living conditions of all South Africans through 
providing/upgrading housing.1 Although over 1 million houses 
had been delivered or were under construction by the end of 
2000,2 there is a paucity of information on the short- and long-
term effects of housing delivery on quality of life and well-
being. A study was therefore conducted involving 334 adult 
residents of an informal settlement in Soweto in 1999 (before 
relocation to a new housing estate or site tenure allocated), and 
in 2001 and 2003 (after relocation). Comparisons were made 
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between three groups, namely new housing estate residents 
(N = 73), site tenure residents (N = 158), and a group living in 
informal housing (N = 103).
From the repeated measures analyses, estimated marginal 
means showed significant group and time effects for overall 
quality of life (Fig. 1). Although there were no differences 
between new housing estate and site tenure residents with re-
gard to quality of life (p > 0.05), both these groups had a better 
quality of life than informal housing residents (p < 0.05). This 
finding was not unexpected as previous research has shown 
that quality of life is very poor in the latter.3 In 2001, quality of 
life was significantly better than in 1999 (p < 0.01), but returned 
to similar levels to 1999 in 2003 (p > 0.05). It is possible that 
changes in living circumstances in 2001 were responsible for 
this effect. A more likely explanation is provided by the classic 
study of the effects of fortune and misfortune on quality of life.4 
The study found that lottery winners’ quality of life shot up, 
while that of accident victims decreased dramatically immedi-
ately after the event, only to return to previous levels at a later 
date.4 
There were no significant group or time effects (p > 0.05) for 
wellbeing (Fig. 1). This lack of group or time effects provides 
support for the model of homeostatic wellbeing.5 Analogous to 
the homeostatic maintenance of blood pressure and tempera-
ture, this model considers that wellbeing is actively controlled 
and maintained by psychological factors that function under 
the influence of personality.5 
Overall findings revealed that access to better housing posi-
tively affects quality of life; there is habituation of quality of life 
in the long term, as people adapt to both positive and negative 
life events; and, irrespective of living conditions, wellbeing is 
maintained at a homeostatic level.
Margaret S Westaway
Health and Development Research Group
Medical Research Council and 
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mwestawa@mrc.ac.za
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Post-exposure prophylaxis for rape 
survivors 
To the Editor: In a recent incident in the Eastern Cape a cocaine 
addict was arrested on drug possession charges and put in a 
holding cell. Sadly, during his time in the cells he was raped. 
Naturally the victim was very concerned about the possibil-
ity of having contracted HIV. However, the attending district 
surgeon refused to provide antiretrovirals (ARVs) as part of 
post-exposure prohylaxis (PEP). SANCA drug counsellors 
were faced with this distressed and traumatised victim when 
he turned to them for help after his release and were quite 
perplexed by the failure of the district surgeon to prescribe PEP 
for 28 days.
Why were the ARVs not provided? One possibility is that 
there may have been a supposition of potential poor medication 
adherence. Predicting a person’s adherence based on specula-
tion would seem to be unfair. Is there in fact proof that sub-
stance dependence causes poor adherence to ARV medication? 
The evidence is mixed, with a review of the issue showing that 
11 of 26 studies found no association with substance abuse.1
The second possibility is that there may have been a concern 
around the pharmacological interaction between cocaine and 
ARVs. One review on the issue does mention an increased risk 
of a cocaine overdose with antiretroviral therapy, citing that 
the administration of a potent CYP 3A4 inhibitor could result 
in a cocaine overdose. ARVs that induce CYP 3A4 activity, 
such as nevirapine, may shift the metabolism of cocaine from 
hydroxylation to N-demethylation and create a higher level of 
the potentially toxic metabolite.2 However the article does not 
mention the likelihood of this event occurring, and nevirapine 
is in any case not used in any PEP regimens.
But are any of these issues relevant considerations in this 
case? Shouldn’t all rape survivors have the right to ARVs, 
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Fig. 1. Overall quality of life (QoL) and wellbeing in 1999, 2001 and 2003 
among new housing estate, site tenure and informal housing residents.
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whether or not they are drug dependent? In our opinion this 
should be a critical part of the medical and psychiatric treat-
ment of the traumatic event.
Andreas Plüddemann 
Alcohol and Drug Abuse Research Unit
Medical Research Council
Cape Town
apluddem@mrc.ac.za
Helmuth Reuter 
Ukwanda Centre for Rural Health
University of Stellenbosch
W Cape
Carol Johnson
Director: SANCA Central Eastern Cape 
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Triage in emergency departments
To the Editor: We value the opportunity to reply to the letter 
by MacFarlane and Naidoo1 regarding triage in South African 
emergency departments (EDs). We note with deep regret the 
recent passing of Professor MacFarlane; the whole emergency 
medicine community will feel his absence.
The triage tool they propose is a modification of a modified 
tool – while both the original Australasian Triage Score and the 
Canadian modification have been shown to work well at iden-
tifying priorities in their settings, there is no evidence that this 
could be extrapolated to our setting. We are not aware of any 
evidence that the suggested modification is evidence based. 
Furthermore, our own studies have shown that the reli-
ability and validity of the triage scores applied are related to 
the complexity of the tool and the level of the triage nurse. We 
would argue that the suggested tool is too complex for enrolled 
nurse assistants (ENAs)/enrolled nurses. It is in this group of 
health care professionals that an available pool of triage nurses 
is likely to be found, and it is this group that the Cape Triage 
Score (CTS) is aimed at.
As the authors point out, the CTS was developed by the Cape 
Triage Group and reported on in this Journal.2 This tool was 
launched across all public EDs in the Western Cape in Janu-
ary 2006, and is also used throughout the MediClinic group 
nationally. The tool was validated on 25 000 patients in both the 
public and private sector, and has been shown to dramatically 
reduce ED waiting times. We have submitted the findings of 
one large study to this Journal, and a number of other articles 
are being written up for publication at this time. While it would 
be inappropriate to pre-empt these articles, we can state that the 
CTS clearly identifies the most ill patients, and performs well 
in distinguishing between other groups of acuity.  It predicts 
death, the need for admission, resource usage and departmental 
length of stay. It further reduces mortality and improves wait-
ing times. Finally, current studies show that ENAs can use the 
tool as accurately as doctors or registered nurses.
We held the inaugural meeting of the South African Triage 
Group (SATG) in Durban in June 2006, consisting of 59 repre-
sentatives from all nine provinces. The SATG has the aim of 
introducing the CTS as a national triage tool – the South African 
Triage Scale (SATS) – throughout the country. The national 
Department of Health has been approached to facilitate this 
process. We will keep readers of this Journal informed of prog-
ress in this regard.
The SATS is a living tool. Research will continue, and if 
changes are required they will be made in time for the Inter-
national Emergency Medicine Conference in South Africa 
(October 2007). In the meantime the SATS is a tool that has been 
developed to fit local needs, and that has been shown to have a 
significant positive impact on patient care.
The Emergency Medicine Society of South Africa has pro-
vided the SATG with a ‘home’, while the Council for Health 
Service Accreditation of South Africa has recognised this triage 
tool. 
Readers wishing to receive more information on the SATS 
should contact capetriage@bvr.co.za or visit www.triagesa.co.za 
Lee A Wallis 
Chair: South African Triage Group 
Clive H Balfour
Chair: Emergency Medicine Society of South Africa
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